Roche Holding AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung Cancer
Completed
- Conditions
- Non-Squamous Non-Small Cell Lung Cancer
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 217
- Registration Number
- NCT01488331
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Completed
- Conditions
- Lymphocytic Leukemia, Chronic
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2017-03-22
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 327
- Registration Number
- NCT01488162
An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in Kenya
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2011-12-02
- Last Posted Date
- 2019-12-23
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 400
- Registration Number
- NCT01484483
- Locations
- 🇰🇪
University of Nairobi School of Medicine; Internal Medicine and Therapeutics, Nairobi, Kenya
A Study of Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis
Phase 2
Completed
- Conditions
- Hepatitis C, Chronic
- Interventions
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 43
- Registration Number
- NCT01483742
A Relative Bioavailability Study of Danoprevir and Ritonavir in Healthy Volunteers
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 36
- Registration Number
- NCT01483729
Evaluation of Accu-Chek DiaPort, a Port System for Continuous Intraperitoneal Insulin Infusion, in Patients With Type I Diabetes
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Device: Accu-Chek DiaPort
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 12
- Registration Number
- NCT01483352
A Human Proof of Concept Study for [11C]-RO5011232 as Radiotracer and Study of the Binding of RO4917523 to Human mGlu5 Brain Receptor at Steady-State in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteer
- Interventions
- Drug: RO5011232Drug: RO4917523
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 56
- Registration Number
- NCT01483469
An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct)
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2019-05-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 215
- Registration Number
- NCT01483326
- Locations
- 🇳🇱
Scheper Ziekenhuis, Emmen, Netherlands
🇳🇱Amphia ziekenhuis, locatie langendijk, Breda, Netherlands
🇳🇱Medisch Centrum Twente; Rheumatology, Enschede, Netherlands
A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Phase 2
Completed
- Conditions
- Hepatitis C, Chronic
- Interventions
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2016-08-05
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 58
- Registration Number
- NCT01482403
A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin
Phase 1
Completed
- Conditions
- Neoplasms
- Interventions
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2017-01-27
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 145
- Registration Number
- NCT01482377
- Locations
- 🇳🇱
Academ Ziekenhuis Groningen; Medical Oncology, Groningen, Netherlands
🇰🇷National Cancer Center, Gyeonggi-do, Korea, Republic of
🇳🇱Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands
© Copyright 2025. All Rights Reserved by MedPath